Claudin-4: a new molecular target for epithelial cancer therapy
R Fujiwara-Tani, S Mori, R Ogata, R Sasaki… - International Journal of …, 2023 - mdpi.com
Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is
overexpressed in many epithelial malignancies and correlates with cancer progression …
overexpressed in many epithelial malignancies and correlates with cancer progression …
Microbiome distinctions between the CRC carcinogenic pathways
L DeDecker, B Coppedge, J Avelar-Barragan… - Gut …, 2021 - Taylor & Francis
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, the third leading
cause of cancer-related deaths, and has been on the rise among young adults in the United …
cause of cancer-related deaths, and has been on the rise among young adults in the United …
[HTML][HTML] Targeting claudins in cancer: diagnosis, prognosis and therapy
J Li - American journal of cancer research, 2021 - ncbi.nlm.nih.gov
Increasing evidence has linked claudins to signal transduction and tumorigenesis. The
expression of claudins is frequently dysregulated in the context of neoplastic transformation …
expression of claudins is frequently dysregulated in the context of neoplastic transformation …
Context-dependent roles of claudins in tumorigenesis
J Li - Frontiers in Oncology, 2021 - frontiersin.org
The barrier and fence functions of the claudin protein family are fundamental to tissue
integrity and human health. Increasing evidence has linked claudins to signal transduction …
integrity and human health. Increasing evidence has linked claudins to signal transduction …
The regulation of the Hippo pathway by intercellular junction proteins
US Ahmad, J Uttagomol, H Wan - Life, 2022 - mdpi.com
The Hippo pathway is an evolutionarily conserved pathway that serves to promote cell death
and differentiation while inhibiting cellular proliferation across species. The downstream …
and differentiation while inhibiting cellular proliferation across species. The downstream …
Gemcitabine resistance in pancreatic ductal carcinoma cell lines stems from reprogramming of energy metabolism
R Fujiwara-Tani, T Sasaki, T Takagi, S Mori… - International Journal of …, 2022 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis because it is
often detected at an advanced stage, and drug resistance interferes with treatment …
often detected at an advanced stage, and drug resistance interferes with treatment …
Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients
Purpose Although there is an established role for microbiome dysbiosis in the pathobiology
of colorectal cancer (CRC), CRC patients of various race/ethnicities demonstrate distinct …
of colorectal cancer (CRC), CRC patients of various race/ethnicities demonstrate distinct …
Functional links between the microbiome and the molecular pathways of colorectal carcinogenesis
Colorectal cancer (CRC) is a common cancer, with a concerning rise in early-onset CRC
cases, signalling a shift in disease epidemiology. Whilst our understanding of the molecular …
cases, signalling a shift in disease epidemiology. Whilst our understanding of the molecular …
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Abstract Background First identified in Drosophila melanogaster, the Hippo pathway is
considered a major regulatory cascade controlling tissue homeostasis and organ …
considered a major regulatory cascade controlling tissue homeostasis and organ …
Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats
GY Gong, SY Xi, CC Li, WL Tang, XM Fu, YP Huang - Phytomedicine, 2023 - Elsevier
Background Benign prostatic hyperplasia (BPH) is a common disease in older men
worldwide. However, there is currently no effective treatment for BPH. Bushen Tongluo …
worldwide. However, there is currently no effective treatment for BPH. Bushen Tongluo …